St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 117   

Articles published

STJ 66.80 +2.53 (3.94%)
price chart
St. Jude Medical (STJ) Shares Cross Above 200 DMA
In trading on Friday, shares of St. Jude Medical, Inc. (Symbol: STJ) crossed above their 200 day moving average of $64.81, changing hands as high as $66.13 per share.
St. Jude Medical Inc. (STJ) Pops 3.94% for November 21
St. Jude Medical Upgraded by Cowen and Company to �Outperform� (STJ)  WKRB News
Related articles »  
Stock Insights on St. Jude Medical, Inc. (NYSE:STJ)
[BUSINESS WIRE] St. Jude Medical, Inc. (NYSE:STJ) (Trend Analysis) a global medical device company, announced U.S.
Company Updates:St. Jude Medical , Audience Inc  Markets Insider
Related articles »  
Bank Of America Tweaks Numbers For St. Jude Medical, Inc. Lower On F/X, Portico
In a report published Monday, Bank of America analyst Bob Hopkins reiterated a Buy rating and $80.00 price target on St. Jude Medical, Inc. (NYSE: STJ). In the report, Bank of America noted, �Given F/X moves since STJ's Q2 call and STJ's guidance that ...
Insider Trading Update:Ptc Inc. , St. Jude Medical
Ptc Inc. (NASDAQ:PTC): Dibona Anthony, EVP Global Support of Ptc Inc. , unloaded 23,919 shares at an average price of $37.41 on November 17, 2014.
Related articles »  
St. Jude Medical Enters Oversold Territory
But making St. Jude Medical, Inc. an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of STJ entered into oversold territory, changing hands as low as $57.01 per share.
Related articles »  
CORRECTED-UPDATE 2-St. Jude Medical lowers forecast; shares fall
Oct 15 (Reuters) - Heart device maker St. Jude Medical Inc on Wednesday forecast fourth-quarter revenue below Wall Street estimates, citing soft international sales and unfavorable foreign exchange rates, and its shares fell nearly 4 percent.
St. Jude Medical Q3 Profit Beats Estimates; Adjusts Q4 Outlook - Quick Facts  NASDAQ
Why St. Jude Medical (STJ) Stock Is Declining Today
Related articles »  
St. Jude Medicals CardioMEMS HF System Tests Positive
St. Jude Medical Inc. (STJ - Analyst Report) has revealed a retrospective data analysis from its CHAMPION trial, conducted to evaluate the safety and efficacy of its CardioMEMS Heart Failure (HF) System on patients with New York Heart Association (NYHA ...
St. Jude Medical's CardioMEMS HF System Tests Positive - Analyst Blog  Nasdaq
Data Shows the CardioMEMS HF System Significantly Reduced 30-Day Hospital ...  MarketWatch
Related articles »  
St. Jude Medical Profit More Than Doubles
The St. Paul, Minn.-based company, which also raised its outlook for the year, has battled industrywide pressures�including pricing pressures from hospitals and insurers�in addition to regulatory and legal scrutiny regarding the frequency and ...
St. Jude Medical (STJ) Stock Is Down Despite Positive Earnings Results
St Jude Medical's quarterly profit doubles as expenses fall  Reuters
Related articles »  
St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force ...
ST. PAUL, Minn., Oct 27, 2014 (BUSINESS WIRE) -- St. Jude Medical, Inc. STJ, +3.94% a global medical device company, today announced U.S.
Stock Update: St. Jude Medical Inc (NYSE:STJ) - St. Jude Medical Receives ...  Jutia Group
Related articles »  
St. Jude Medical, Inc. Still Feeling the Love
I thought St. Jude Medical (NYSE: STJ ) was already getting a fair bit of the benefit of the doubt back in April, but Wall Street has continued to bid these shares up on growing hopes that new products from the pipeline will drive revenue growth back ...